Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cathomas

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Journal of Cancer|January 19, 2018
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient ProgramCatharina Balmelli, Nikola Railic, Marco Siano, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2023
Safety profile of darolutamide versus placebo: a systematic review and meta-analysisFabio Turco, Silke Gillessen, Giorgio Treglia, et al.
Clinical Genitourinary Cancer|March 6, 2018
Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in SwitzerlandNadja Sandmeier, Sacha I Rothschild, Christian Rothermundt, et al.
Plos One|September 17, 2013
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancerFlorent Baty, Sacha Rothschild, Martin Früh, et al.
Cancers|November 13, 2021
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current EvidenceSara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Urologia Internationalis|May 8, 2014
Management of bone metastases in patients with castration-resistant prostate cancerRichard Cathomas, Zoltan Bajory, Mounira Bouzid, et al.
Journal of Cancer|September 27, 2013
Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled TrialFrank Stenner-Liewen, Heike Liewen, Richard Cathomas, et al.
Prostate Cancer and Prostatic Diseases|April 13, 2023
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapyLuca Afferi, Mattia Longoni, Marco Moschini, et al.
Oncology|June 9, 2012
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinomaFrank Stenner, Rahel Chastonay, Heike Liewen, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Journal of Cancer|January 19, 2018
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient ProgramCatharina Balmelli, Nikola Railic, Marco Siano, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2023
Safety profile of darolutamide versus placebo: a systematic review and meta-analysisFabio Turco, Silke Gillessen, Giorgio Treglia, et al.
Clinical Genitourinary Cancer|March 6, 2018
Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in SwitzerlandNadja Sandmeier, Sacha I Rothschild, Christian Rothermundt, et al.
Plos One|September 17, 2013
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancerFlorent Baty, Sacha Rothschild, Martin Früh, et al.
Cancers|November 13, 2021
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current EvidenceSara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Urologia Internationalis|May 8, 2014
Management of bone metastases in patients with castration-resistant prostate cancerRichard Cathomas, Zoltan Bajory, Mounira Bouzid, et al.
Journal of Cancer|September 27, 2013
Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled TrialFrank Stenner-Liewen, Heike Liewen, Richard Cathomas, et al.
Prostate Cancer and Prostatic Diseases|April 13, 2023
Health-related quality of life in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors: the role of combination treatment therapyLuca Afferi, Mattia Longoni, Marco Moschini, et al.
Oncology|June 9, 2012
A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinomaFrank Stenner, Rahel Chastonay, Heike Liewen, et al.
Pageof 14